Concepedia

Janneke S. Hoogstad‐van Evert

JS

Statistics

Publications

9

Citations

403

H-Index

9

Active since

2017

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

University Medical Center

Radboud Institute for Molecular Life Sciences

Amphia Ziekenhuis

Janneke S. Hoogstad‐van Evert is an author at Radboud University Medical Center specializing in t cell immunity, immune regulation, and tumor immunity.

ORCID

Top concepts

Publications per year

2017–2024

9

Publications

9

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

Janneke S. Hoogstad‐van Evert, Ralph J. A. Maas, Jolien M.R. Van der Meer et al. · Oncotarget · 2018 · 70 citations · Full text

Umbilical cord blood CD34<sup>+</sup>progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg<sup>null</sup>mice

Janneke S. Hoogstad‐van Evert, Jeannette Cany, Dirk van den Brand et al. · OncoImmunology · 2017 · 65 citations · Full text

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer et al. · OncoImmunology · 2020 · 65 citations · Full text

Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice

Jeannette Cany, Mieke W.H. Roeven, Janneke S. Hoogstad‐van Evert et al. · Blood · 2017 · 57 citations · Full text

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall et al. · Cancer Immunology Immunotherapy · 2020 · 43 citations · Full text

, , +21

1–5 of 9